The Cooper Companies, Inc. (NASDAQ:COO) Receives $110.25 Consensus Price Target from Brokerages

Shares of The Cooper Companies, Inc. (NASDAQ:COO) have earned a consensus rating of “Moderate Buy” from the ten ratings firms that are currently covering the company, MarketBeat Ratings reports. Three analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1-year price target among brokerages that have issued ratings on the stock in the last year is $110.25.

Several equities analysts recently commented on the company. Robert W. Baird dropped their price objective on Cooper Companies from $117.00 to $107.00 and set an “outperform” rating on the stock in a research note on Friday, March 7th. JPMorgan Chase & Co. cut their price target on Cooper Companies from $120.00 to $110.00 and set an “overweight” rating for the company in a research note on Friday, March 7th. Stifel Nicolaus decreased their price objective on Cooper Companies from $115.00 to $105.00 and set a “buy” rating for the company in a report on Friday, March 7th. Citigroup lowered their price objective on Cooper Companies from $115.00 to $110.00 and set a “buy” rating on the stock in a research note on Friday, March 7th. Finally, Piper Sandler reiterated an “overweight” rating and set a $115.00 target price (down previously from $120.00) on shares of Cooper Companies in a research report on Friday, March 7th.

Cooper Companies Trading Up 1.8%

NASDAQ:COO opened at $82.92 on Wednesday. Cooper Companies has a 52 week low of $69.81 and a 52 week high of $112.38. The firm has a 50-day moving average price of $80.19 and a two-hundred day moving average price of $90.20. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The firm has a market cap of $16.58 billion, a price-to-earnings ratio of 42.52, a price-to-earnings-growth ratio of 2.25 and a beta of 1.08.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, hitting analysts’ consensus estimates of $0.92. The company had revenue of $964.70 million for the quarter, compared to analysts’ expectations of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. On average, equities analysts expect that Cooper Companies will post 3.98 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Cooper Companies

A number of institutional investors and hedge funds have recently modified their holdings of COO. T. Rowe Price Investment Management Inc. increased its holdings in Cooper Companies by 2.1% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 7,678,965 shares of the medical device company’s stock worth $705,928,000 after acquiring an additional 155,233 shares during the period. JPMorgan Chase & Co. grew its position in shares of Cooper Companies by 3.4% during the 1st quarter. JPMorgan Chase & Co. now owns 5,177,008 shares of the medical device company’s stock valued at $436,681,000 after purchasing an additional 172,485 shares in the last quarter. Geode Capital Management LLC increased its holdings in shares of Cooper Companies by 2.3% in the fourth quarter. Geode Capital Management LLC now owns 4,906,463 shares of the medical device company’s stock worth $449,907,000 after purchasing an additional 109,907 shares during the period. Goldman Sachs Group Inc. raised its position in shares of Cooper Companies by 17.0% in the first quarter. Goldman Sachs Group Inc. now owns 4,734,327 shares of the medical device company’s stock worth $399,340,000 after buying an additional 686,751 shares in the last quarter. Finally, Victory Capital Management Inc. grew its position in Cooper Companies by 14.6% during the fourth quarter. Victory Capital Management Inc. now owns 4,525,018 shares of the medical device company’s stock worth $415,985,000 after buying an additional 574,899 shares in the last quarter. 24.39% of the stock is owned by hedge funds and other institutional investors.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.